COVID-19-induced pancytopenia in a major molecular response CML patient on dasatinib: A case report and review of the literature

Balraj Singh, Sarah Ayad, Parminder Kaur, Vinod Kumar, Sachin Gupta, Michael Maroules

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has caused a global health crisis. COVID-19 can have a multifaceted presentation, and a wide range of complications and outcomes may emerge based on the severity and comorbidities of the infected patient. We report the case of a 42-year-old man with a history of chronic myeloid leukaemia (CML) on dasatinib (in major molecular response) who was diagnosed with COVID-19 and developed pancytopenia. Our case report and review of available publications add to the limited literature available regarding COVID-19 in CML.

Original languageEnglish (US)
JournalEuropean Journal of Case Reports in Internal Medicine
Issue number1
StatePublished - 2021

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this